Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Pre Market
Current status date:
2019-06-03
Original market date: See footnote 1
Product name:
NAPROXEN CAPSULES 200 MG
DIN:
02422743
Product Monograph/Veterinary Labelling:
Date:
2014-04-22
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ACCUCAPS INDUSTRIES LIMITED
2125 Ambassador Drive
Windsor
Ontario
Canada
N9C 3R5
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
28:08.04.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
M01AE02 NAPROXEN
Active ingredient group (AIG) number:See footnote5
0255210001
| Active ingredient(s) | Strength |
|---|---|
| NAPROXEN | 105 MG |
| NAPROXEN SODIUM | 105 MG |